Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CTC cisplatin sensitivity profile in metastatic breast cancer
NL-OMON44123Active, not recruiting
- Sponsor
- Erasmus MC Cancer Institute
- Start
- Jun 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label trial of cisplatin in breast cancer (3 arms), sponsored by Erasmus MC Cancer Institute. Primary endpoint: Response rate. Started Jun 2013; status: active, not recruiting.
02
Drugs
cisplatin
03
Conditions
breast cancer
Beyond the preview
Go deeper on NL-OMON44123.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON44123.